AstraZeneca may have included out-of-date drug data in information provided during US trials for its Covid-19 vaccine, a regulator said late Monday, citing concerns from a monitoring board.
The board "expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data," a statement from the National Institute of Allergy and Infectious Diseases said.
Copyright © 2012 Naharnet.com. All Rights Reserved. | https://mobile.naharnet.com/stories/en/280359 |